131 related articles for article (PubMed ID: 22511078)
1. [Can the immune system target cancer?].
Olweus J; Kolstad A
Tidsskr Nor Laegeforen; 2012 Apr; 132(7):784-5. PubMed ID: 22511078
[No Abstract] [Full Text] [Related]
2. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
[TBL] [Abstract][Full Text] [Related]
3. [Immunotherapy of cancer (some immunological problems in cancer therapy)].
Izumi T
Bull Chest Dis Res Inst Kyoto Univ; 1973 Dec; 7(1):58-65. PubMed ID: 4135979
[No Abstract] [Full Text] [Related]
4. beta-Glycosphingolipids as immune modulators.
Adar T; Ilan Y
J Immunotoxicol; 2008 Apr; 5(2):209-20. PubMed ID: 18569392
[TBL] [Abstract][Full Text] [Related]
5. What's new in surgical oncology: impact of immunology and tumour biology.
Heys SD; Eremin O
J R Coll Surg Edinb; 1990 Dec; 35(6):341-4. PubMed ID: 2086793
[No Abstract] [Full Text] [Related]
6. Immunogenic anti-cancer chemotherapy as an emerging concept.
Haynes NM; van der Most RG; Lake RA; Smyth MJ
Curr Opin Immunol; 2008 Oct; 20(5):545-57. PubMed ID: 18573339
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy in children: report from the Reisensburg-Symposium October 20-22, 2004 and recent advances.
Klingebiel T; Bader P; Hollatz G; Koehl U; Lehrnbecher T; Meisel R; Dilloo D
Klin Padiatr; 2006; 218(6):355-65. PubMed ID: 17080339
[TBL] [Abstract][Full Text] [Related]
8. JAMA Oncology Patient Page. Immune Checkpoint Inhibitors.
West HJ
JAMA Oncol; 2015 Apr; 1(1):115. PubMed ID: 26182315
[No Abstract] [Full Text] [Related]
9. Waking the immune system at last.
Bates SE
Clin Cancer Res; 2013 Mar; 19(5):996. PubMed ID: 23460530
[No Abstract] [Full Text] [Related]
10. New drugs help immune system fight cancer.
McBride D
ONS Connect; 2012 Aug; 27(8):25. PubMed ID: 22873087
[No Abstract] [Full Text] [Related]
11. Biological response modifiers (BRM), chemotherapy, and activated cytotoxic leukocyte subsets: strategies for rational design of apheresis-based cancer immunotherapies.
Stevenson HC; Klein HG
Prog Clin Biol Res; 1990; 337():559-65. PubMed ID: 2353018
[No Abstract] [Full Text] [Related]
12. [Anticancer immunity and cancer immunotherapy with cell wall skeleton and related synthetic compounds (author's transl)].
Yamamura Y
Nihon Naika Gakkai Zasshi; 1981 Aug; 70(8):1083-90. PubMed ID: 6975338
[No Abstract] [Full Text] [Related]
13. Immunological techniques: ex vivo characterization of T cell-mediated immune responses in cancer.
Speiser DE
Curr Opin Immunol; 2005 Aug; 17(4):419-22. PubMed ID: 15955683
[No Abstract] [Full Text] [Related]
14. [Cancer immunotherapy: immunologic bases, reality and hopes].
Dietrich PY; Farace F; Caignard A; Escudier B; Triebel F
Bull Cancer; 1993 Jul; 80(7):584-600. PubMed ID: 8204939
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 15 as a promising candidate for tumor immunotherapy.
Jakobisiak M; Golab J; Lasek W
Cytokine Growth Factor Rev; 2011 Apr; 22(2):99-108. PubMed ID: 21531164
[TBL] [Abstract][Full Text] [Related]
16. [Augmentation of antitumor immunity in cancer chemotherapy].
Hosokawa M; Kobayashi H
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1402-6. PubMed ID: 1697151
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory effects of sorafenib on peripheral immune effector cells in metastatic renal cell carcinoma.
Busse A; Asemissen AM; Nonnenmacher A; Braun F; Ochsenreither S; Stather D; Fusi A; Schmittel A; Miller K; Thiel E; Keilholz U
Eur J Cancer; 2011 Mar; 47(5):690-6. PubMed ID: 21215610
[TBL] [Abstract][Full Text] [Related]
18. [Immunotherapy of cancer].
Andersen MH; Schmidt H; Gehl J; von der Maase H; Straten P
Ugeskr Laeger; 2002 Jun; 164(23):3008-16. PubMed ID: 12082849
[TBL] [Abstract][Full Text] [Related]
19. Mitoxantrone in multiple sclerosis.
Neuhaus O; Kieseier BC; Hartung HP
Adv Neurol; 2006; 98():293-302. PubMed ID: 16400840
[No Abstract] [Full Text] [Related]
20. Cytotoxic T-lymphocyte-associated antigen-4.
Salama AK; Hodi FS
Clin Cancer Res; 2011 Jul; 17(14):4622-8. PubMed ID: 21467163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
